The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...

WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and ...

USC baseball certainly appears to be on the upswing right now. The Trojans are coming off of a season in which they made the ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

As President Donald Trump huddled with his top advisers in the White House Situation Room on Tuesday, U.S. officials signaled ...

THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the ...

Brain scientists have made a breakthrough that could help diagnose Parkinson's disease and Multiple System Atrophy much ...

The Korea Research Institute of Chemical Technology's new MoS2 coating boosts the lifespan of anode-free solid-state ...

Nearly 11 years after Theresa Benn's body was discovered in Choccolocco Creek, investigators have returned to a rural stretch ...

Developers have struck a deal with lenders including a hedge fund to end a decade-long impasse over an historic Venetian ...

Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.